Zoloft and Erythrocyte sedimentation rate increased - a phase IV clinical study of FDA data

Summary:

Erythrocyte sedimentation rate increased is reported as a side effect among people who take Zoloft (sertraline hydrochloride), especially for people who are female, 50-59 old, also take Atarax,.

The phase IV clinical study analyzes which people have Erythrocyte sedimentation rate increased when taking Zoloft. It is created by eHealthMe based on reports of 128,159 people who have side effects when taking Zoloft from the FDA, and is updated regularly.

What is Zoloft?

Zoloft has active ingredients of sertraline hydrochloride. It is often used in depression. eHealthMe is studying from 138,798 Zoloft users. Check the latest studies of Zoloft.

What is Erythrocyte sedimentation rate increased?

Erythrocyte sedimentation rate increased is found to be associated with 176 drugs and 1 condition by eHealthMe. Check the latest studies of Erythrocyte sedimentation rate increased.

On Jul, 10, 2026

128,159 people reported to have side effects when taking Zoloft.
Among them, 37 people (0.03%) have Erythrocyte sedimentation rate increased.

Could Zoloft cause Erythrocyte sedimentation rate increased?

Among these 37 people:

What is the gender of people who have Erythrocyte sedimentation rate increased when taking Zoloft? *

female: 94.59 %
male: 5.41 %

What is the age of people who have Erythrocyte sedimentation rate increased when taking Zoloft? *

What are other drugs people take besides Zoloft? *

What are other side effects people have besides Erythrocyte sedimentation rate increased? *

Weakness: 13 people, 35.14%
Liver Function Tests Nos Abnormal: 11 people, 29.73%
Haemoglobin Decreased: 10 people, 27.03%
Fever: 9 people, 24.32%
Haematocrit Decreased: 8 people, 21.62%
Nausea (feeling of having an urge to vomit): 8 people, 21.62%
Fatigue (feeling of tiredness): 7 people, 18.92%
Red Blood Cell Count Decreased: 7 people, 18.92%
High Blood Cholesterol: 6 people, 16.22%
Lymph Follicular Hypertrophy (an increase in the size of the lymph node follicles): 6 people, 16.22%

* Approximation only. Some reports may have incomplete information.

Do you take Zoloft and have Erythrocyte sedimentation rate increased?

- Check whether Erythrocyte sedimentation rate increased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Zoloft:

Zoloft (138,798 reports)

Erythrocyte sedimentation rate increased treatments and more:

Erythrocyte sedimentation rate increased (2,164 reports)

How severe was Erythrocyte sedimentation rate increased and when was it recovered:

Erythrocyte sedimentation rate increased in Zoloft

Expand to all the drugs that have ingredients of sertraline hydrochloride:

Erythrocyte sedimentation rate increased and drugs with ingredients of sertraline hydrochloride (42 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Zoloft:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Erythrocyte sedimentation rate increased:

Erythrocyte sedimentation rate increased (176 drugs)

Browse all the conditions that are associated with Erythrocyte sedimentation rate increased:

Erythrocyte sedimentation rate increased (1 condition)

Related publications that referenced our studies

Izgi C, Erdem G, Mansuroglu D, Kurtoglu N, Kara M, Gunesdogdu F, "Severe hypokalemia probably associated with sertraline use", Annals of Pharmacotherapy, 2014 Jan .
Izgi C, Erdem G, Mansuroglu D, Kurtoglu N, Kara M, Gunesdogdu F, "Severe hypokalemia probably associated with sertraline use", Annals of Pharmacotherapy, 2014 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on sertraline hydrochloride (the active ingredients of Zoloft) and Zoloft (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.